शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
KOPRANBSEKOPRAN LTD· PharmaceuticalsMediumNeutral
Announced Tue, 3 Nov, 2026 · 15:09 IST

Q2 FY2026-27 revenue and profit rebound

KOPRAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.5%Reaction day
₹243.57
prior close
₹247.28
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+1.3% vs market

On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.6
10m
-1.2
15m
-0.4
30m
—
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
+1.5+0.3+1.3
Next day
+3.8+2.4+1.3
2d
+9.0+3.6+5.5
3d
+7.9pendingpending
4d
———
5d
———
1w
———
15d
———
1m
———
2m
———
3m
———
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kopran's Q2 FY2026-27 revenue was Rs 21,126 lakh, up from Rs 11,791 lakh a year earlier. Operating profit before interest, tax, depreciation and amortisation rose to Rs 1,822 lakh from Rs 299 lakh, lifting the margin to 8.62% from 2.53%. Net profit was Rs 439 lakh versus a Rs 992 lakh loss. First-half revenue was Rs 36,526 lakh and net profit Rs 1,110 lakh. Finance costs and borrowings increased.

Likely market impact

The profit rebound and wider margin support positive sentiment, while higher finance costs and borrowings remain concerns.